Data is not available at this time.
Auna SA operates in the healthcare sector, primarily focusing on integrated health services across Latin America. The company generates revenue through a diversified model encompassing health insurance, hospital operations, and outpatient care, serving both individual and corporate clients. Its vertically integrated approach allows for cost efficiencies and cross-selling opportunities, positioning it as a key player in the region's growing healthcare market. Auna competes by leveraging scale, technology, and strategic partnerships to enhance accessibility and quality of care. The company’s market position is reinforced by its strong brand recognition and focus on premium services, targeting middle-to-high-income segments. With healthcare demand rising due to demographic shifts and increasing insurance penetration, Auna is well-placed to capitalize on long-term sector tailwinds. Its ability to navigate regulatory complexities and maintain operational excellence further strengthens its competitive edge in a fragmented industry.
Auna reported revenue of $4.39 billion for FY 2024, with net income of $110.3 million, reflecting a net margin of approximately 2.5%. Operating cash flow stood at $668.5 million, indicating robust cash generation relative to earnings. Capital expenditures of $90.9 million suggest disciplined reinvestment, supporting growth without excessive outlays. The company’s efficiency metrics highlight a balance between expansion and profitability.
Diluted EPS of $1.63 demonstrates Auna’s earnings power, supported by its scalable operations. The company’s capital efficiency is evident in its ability to convert revenue into operating cash flow at a 15.2% rate. With a focus on optimizing asset utilization, Auna maintains a lean cost structure, though its high debt load warrants monitoring for long-term sustainability.
Auna’s balance sheet shows $235.7 million in cash against total debt of $3.77 billion, indicating significant leverage. While the debt level raises liquidity concerns, the strong operating cash flow provides some cushion. The company’s ability to service debt will depend on maintaining stable earnings and cash generation, particularly in a volatile macroeconomic environment.
Auna’s growth is driven by organic expansion and strategic acquisitions in Latin America’s healthcare market. The company declared a modest dividend of $0.02 per share, signaling a conservative payout policy aimed at retaining capital for reinvestment. Future growth will likely hinge on regional demand trends and execution of operational improvements.
With a market capitalization derived from 67.7 million shares outstanding, Auna’s valuation reflects investor expectations for sustained growth in healthcare demand. The company’s premium positioning and integrated model may justify a higher multiple, but leverage and regional risks could temper optimism.
Auna’s strategic advantages include its integrated healthcare ecosystem and strong regional presence. The outlook remains positive, supported by demographic trends and underpenetrated markets, though regulatory and macroeconomic risks persist. Execution on cost control and debt management will be critical to sustaining long-term value creation.
Company filings, CIK 0001799207
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |